Product Details

This product includes instant access to the PDF/eBook and 10-CME Post-Test. Print copies will ship in the second week of November.

Insights from research to enhance your clinical work 

As a clinician, you need to keep up on the latest developments in psychiatry. But you can’t possibly read every potentially relevant research study published each year. At Carlat Publishing, we try to make your life easier by sifting through the contents of the major psychiatric journals for you. The studies that meet our criteria—tackling interesting topics and yielding actionable recommendations for your practice—have made it into our new edition of Psychiatry Practice Boosters. 

This fifth edition teaches you the key points of 66 of the most clinically relevant studies in psychiatry from the last three years. This book includes a quick course in how to understand research design and statistics—so that you can be a more informed reader of the medical literature. 

Take a look inside with this PDF of free sample pages.

Get research-based insight into these vital questions: 

• How can we safely treat OUD in pregnancy? 
• What are long-term patient outcomes with buprenorphine for OUD? 
• What is the latest on medications for panic disorders? 
• Is there a connection between depression and Alzheimer’s disease? 
• Is magnetic seizure therapy effective in mood disorders? 
• How much is social media really impacting mental health? 

Table of Contents

Acknowledgments Introduction A Clinician’s Primer on Scientific Research

Addiction Psychiatry

• Are MOUD Associated With New Cardiac Arrhythmias

• Buprenorphine Versus Methadone for OUD in Pregnancy

• Buprenorphine Versus Methadone for Prescription OUD

• Cannabis Use Frequency and Cannabis Use Disorder

• Can Psilocybin Treat Alcohol Use Disorder

• Daily Alcohol Intake and Risk for All-Cause Mortality

• Deep Brain Stimulation for Severe Alcohol Use Disorder

• How Do We Help Depressed Smokers Quit

• Long-Term Patient Outcomes With Buprenorphine for OUD

• Methamphetamine Withdrawal Treatment

• Perinatal MOUD Use and Infant Discharge to Biological Parents

• Treating OUD in a Multidisciplinary Clinic During the Peripartum Period

ADHD

• Effectiveness of Unlicensed Stimulant Doses for Adult ADHD

• Reliability of ADHD Screening Tools

Anxiety and Compulsive Disorder

• Benzodiazepines, Quetiapine, and Pregabalin for Short-Term Anxiety

• Memantine for Trichotillomania and Excoriation Disorder

• Mirtazapine Augmentation in OCD

• Which Meds Are Best for Panic Disorder

Child and Adolescent Psychiatry

• Autistic Drivers Perform Well

• Gender-Affirming Hormones for Adolescents

• Is It Worth Adding Coenzyme Q10 to Atomoxetine for ADHD

• Olanzapine and Samidorphan: A Promising Combo

• Physical Activity for Depression in Youth: A Closer Look at the Data

• Stimulant Treatment Effect on Anxiety in ADHD

• Testing Neurofeedback for ADHD

• Ziprasidone for Bipolar Mania in Children and Teens

Geriatric Psychiatry

• Assessment of Stimulant Use and Cardiovascular Event Risk Among Older Adults

• Can Physical Activity Offset Cognitive Decline

• Do Psychosocial Interventions Improve Quality of Life in Advanced Dementia

• Enhancing Antidepressant Efficacy in Older Adults

• Is Neuropsych Testing Better Than the MoCA for Diagnosing Mild Cognitive Impairment

• Linking Alzheimer’s and Depression in Patients After 50

• Lithium Therapy in Older Adults: Expert Recommendations

• Moderate Alcohol Use, Iron, and Cognitive Decline

• Smartphone Apps Benefit Memory and Quality of Life

• Therapy in Dementia? Choose CBT

Managing Adverse Effects

• Antipsychotic Polypharmacy: Maybe Not So Risky After All

• Lithium and Valproate Have Low (and Similar) Risks of Kidney Injury

• Strategies to Reduce Antipsychotic-Induced Hyperprolactinemia

• Why Should We Care About Hyperprolactinemia With Antipsychotic Use

Mood Disorders

• Adjuvant Clonidine for Mania

• Brexpiprazole for Resistant Depression

• Cariprazine Augmentation for Major Depression

• Dextromethorphan-Bupropion (Auvelity): A Novel Mechanism for Major Depression

• Do Antidepressants Have a Role in Acute Bipolar Depression

• Does Psychiatric Hospitalization Prevent Suicide Attempts

• ECT and Risk of Suicide in Major Depression

• L-Methylfolate Offers Modest Boost to Antidepressants

• Magnetic Seizure Therapy: A Safer, Gentler Alternative to ECT

• Mitochondrial Modulators and Bipolar Depression

• Sublingual Dexmedetomidine (Igalmi) for Acute Agitation in Bipolar Disorder

• Surprise Result for Adherence in Bipolar Disorder

• Top Augmentation Strategies for Treatment-Resistant Depression

Psychotherapy

• DBT for Borderline Personality Disorder: Is Half the “Dose” Effective

• Enhancing PTSD Therapy With Aerobic Exercise: A New Approach

• Is CBT Really All That Jazz for Depression

• Optimizing Sleep Timing for Night-Shift Workers

• Psychological Benefits of Abstaining From Social Media

Schizophrenia

• How Long Should We Wait Before Changing Antipsychotics in Schizophrenia

• Immediate-Release Versus Extended-Release Quetiapine for Schizophrenia

• Negative Symptoms of Schizophrenia: A Target for TMS

• Pimavanserin and Negative Symptoms of Schizophrenia

Women’s Mental Health

• Antipsychotics in Pregnancy and Risk of Neurodevelopmental Disorders

• Does Menopause Increase Psychosis Risk

• Perinatal Bipolar Mood Episodes: More Prevalent Than We Thought

• Proposed Treatment Algorithm for Postpartum Psychosis